
Hindraj Pharmaceuticals Private Limited
About Hindraj Pharmaceuticals Private Limited
Data last updated:
Hindraj Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the manufacturing segment of the food and beverages sector. It was incorporated on 10 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24304DL2020PTC371271.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nazra and Mohd Shahid Salmani.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at F – 3/745 G/F Sangam Vihar, Delhi, India – 110062.
As per the financials filed for FY 2023, the company reported a revenue of ₹1.88 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹13,904 (net margin -7.4%) and EBITDA of -₹13,904 (EBITDA margin -7.4%).
Company details
Contact details
Hindraj Pharmaceuticals Private Limited's registered office is in Delhi, Delhi.
- Registered AddressF – 3/745 G/F Sangam Vihar, Delhi, India – 110062
- IndustryFood And Beverages, Manufacturing, Artificial Fibres
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Hindraj Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Hindraj Pharmaceuticals Private Limited, buy the company report.
Financials of Hindraj Pharmaceuticals Private Limited
FY 2023 filings availableHindraj Pharmaceuticals Private Limited reported revenue of ₹1.88 Lakh (up 795% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 795% in the latest year. EBITDA rose 27% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹13,904 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹13,904 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -7.4% | ||
| Net Profit Margin | -7.4% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Hindraj Pharmaceuticals Private Limited, buy the company report.
Board of directors of Hindraj Pharmaceuticals Private Limited
Hindraj Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nazra | Director | 10 Oct 2020 | 6 Years 1 Months | Current |
| Mohd Shahid Salmani | Director | 10 Oct 2020 | 6 Years 1 Months | Current |
Peer comparison
Hindraj Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Neophyte Pharmaceuticals Private Limited | ₹1.91 Lakh (FY 2024) | -72.0% | Patna, Bihar, India | |||
| Vindhyachal Pharmaceuticals Private Limited | ₹1.89 Lakh (FY 2019) | -94.0% | Umarkhed, Maharashtra, India | |||
| Megsan Pharmaceuticals Private Limited | ₹1.89 Lakh (FY 2025) | -35.0% | Cuttack, Odisha, India | |||
| Experon Pharmaceuticals Private Limited | ₹1.88 Lakh (FY 2025) | -51.0% | Gorakhpur, Uttar Pradesh, India | |||
| Hindraj Pharmaceuticals Private Limitedthis company | ₹1.88 Lakh (FY 2023) | -₹13,904 | -7.4% | 795.0% | Delhi, India | |
| Sofitt Pharmaceuticals Private Limited | ₹1.87 Lakh (FY 2020) | Pataudi, Haryana, India |
To see the full peer comparison of Hindraj Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Hindraj Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hindraj Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Hindraj Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Hindraj Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Mohd Shahid Salmani was appointed as Director on 10 Oct 2020.
Frequently asked questions
Hindraj Pharmaceuticals is an active private limited company based in Delhi, India. The company works in manufacturing, within the food and beverages industry. It was incorporated on 10 October 2020 (6+ years old) and is registered under CIN U24304DL2020PTC371271.
Hindraj Pharmaceuticals has 2 current directors:
- Nazra - Director
- Mohd Shahid Salmani - Director
The latest financial statements of Hindraj Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Hindraj Pharmaceuticals is U24304DL2020PTC371271. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hindraj Pharmaceuticals was incorporated on 10 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Hindraj Pharmaceuticals by revenue are Neophyte Pharmaceuticals Private Limited, Vindhyachal Pharmaceuticals Private Limited, Megsan Pharmaceuticals Private Limited, Experon Pharmaceuticals Private Limited, Sofitt Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Mohd Shahid Salmani was appointed as Director on 10 Oct 2020. Nazra was appointed as Director on 10 Oct 2020.
The registered office of Hindraj Pharmaceuticals is at F – 3745 GF Sangam Vihar, Delhi, India – 110062.
Hindraj Pharmaceuticals operates in the food and beverages industry, in the manufacturing segment.
Hindraj Pharmaceuticals can be reached at its registered office: F – 3745 GF Sangam Vihar, Delhi, India – 110062.
Hindraj Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.

